Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis

被引：0
|
作者：
Dipen Patel
Ahmed Shelbaya
Raymond Cheung
Jyoti Aggarwal
Sang Hee Park
Javier Coindreau
机构：
[1] Pharmerit International,
[2] Pfizer Inc,undefined
[3] Columbia University Mailman School of Public Health,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
Biologic; Biosimilar; Cost-effectiveness; Early intervention; Methotrexate; Rheumatology; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2086 / 2095
页数：9
相关论文
共 50 条
  • [1] Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis
    Patel, Dipen
    Shelbaya, Ahmed
    Cheung, Raymond
    Aggarwal, Jyoti
    Park, Sang Hee
    Coindreau, Javier
    ADVANCES IN THERAPY, 2019, 36 (08) : 2086 - 2095
  • [2] Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis
    Finckh, Axel
    Bansback, Nick
    Liang, Matthew H.
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (05) : 333 - 334
  • [3] Cost-Effectiveness of Biologics in Early Rheumatoid Arthritis RESPONSE
    Boers, Maarten
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (05) : 334 - 334
  • [4] Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis
    Peng, Kuan
    Chan, Shirley C. W.
    Wang, Yang
    Cheng, Franco W. T.
    Yeung, Winnie W. Y.
    Jiao, Yuanshi
    Chan, Esther W. Y.
    Wong, Ian C. K.
    Lau, Chak-Sing
    Li, Xue
    JAMA NETWORK OPEN, 2024, 7 (06) : e2418800
  • [5] EARLY INTERVENTION WITH BIOSIMILARS COMPARED WITH LEFLUNOMIDE IN ESTABLISHED RHEUMATOID ARTHRITIS: A COST-EFFECTIVENESS ANALYSIS IN HONG KONG
    Peng, K.
    Chan, S. C. W.
    Wang, Y.
    Cheng, F. W. T.
    Yeung, W. W. Y.
    Jiao, Y.
    Wong, I. C. K.
    Lau, C. S.
    Li, X.
    VALUE IN HEALTH, 2023, 26 (12) : S195 - S195
  • [6] The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review
    Joensuu, Jaana T.
    Huoponen, Saara
    Aaltonen, Kalle J.
    Konttinen, Yrjo T.
    Nordstrom, Dan
    Blom, Marja
    PLOS ONE, 2015, 10 (03):
  • [7] COST-EFFECTIVENESS OF ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN CHILE
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    VALUE IN HEALTH, 2013, 16 (03) : A223 - A223
  • [8] Cost-effectiveness of treatment strategies for rheumatoid arthritis patients with inadequate response to methotrexate
    Patel, VD
    Hay, J
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [9] Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists
    Eline van Overbeeke
    Birgit De Beleyr
    Jan de Hoon
    Rene Westhovens
    Isabelle Huys
    BioDrugs, 2017, 31 : 447 - 459
  • [10] Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists
    van Overbeeke, Eline
    De Beleyr, Birgit
    de Hoon, Jan
    Westhovens, Rene
    Huys, Isabelle
    BIODRUGS, 2017, 31 (05) : 447 - 459
12345